1. Home
  2. ASYS vs CNTB Comparison

ASYS vs CNTB Comparison

Compare ASYS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$12.98

Market Cap

164.5M

Sector

Technology

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$2.69

Market Cap

128.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
CNTB
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
128.6M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ASYS
CNTB
Price
$12.98
$2.69
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
171.8K
110.5K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
75.22
EPS
0.01
N/A
Revenue
$79,364,000.00
$26,033,000.00
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
$24,617.69
P/E Ratio
$1,278.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$0.51
52 Week High
$18.59
$3.28

Technical Indicators

Market Signals
Indicator
ASYS
CNTB
Relative Strength Index (RSI) 48.02 51.52
Support Level $11.60 $2.09
Resistance Level $13.26 $2.86
Average True Range (ATR) 0.79 0.20
MACD 0.06 0.02
Stochastic Oscillator 47.20 44.78

Price Performance

Historical Comparison
ASYS
CNTB

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Share on Social Networks: